Test Enanthate 250mg/mL | 10-Vial
AR baseline · ~7 day t½ · Aromatizes
QSC Peptides · 100:100
$280Buy →
≥99% Pure · COA
A moderate-aromatization, high-selectivity research combination: Testosterone Enanthate (foundational AR + E2), Equipoise 300mg/mL (Δ1-testosterone, 50% aromatization, EPO stimulation, ~14 day t½), and Anavar 50mg (322:24 ratio, renal excretion, no aromatization). Studying distinct androgen receptor selectivity profiles across three structural classes.
Shop All QSC Steroids →QSC Peptides · 100:100
QSC Peptides · ~50% aromatization
QSC Peptides · DHT 2-oxa
| Compound | A:A Ratio | Aromatizes | Half-Life | Unique Feature |
|---|---|---|---|---|
| Test Enanthate | 100:100 | → E2 (full) | ~7 days | Reference · DHT conversion |
| Equipoise (EQ) | 100:50 | → E1/E2 (~50% Test) | ~14 days | EPO stimulation · Longest t½ |
| Anavar | 322:24 | No | ~9 hrs (oral) | Renal excretion · Highest selectivity |
This stack uniquely combines a testosterone ester (Class 1), a Δ1-testosterone derivative (Class 5 specialty), and a DHT oral (Class 3) — allowing simultaneous study of three different AR binding profiles and pharmacokinetic windows in a single research design.
Boldenone Undecylenate (EQ) adds two distinct research variables unavailable from testosterone or anavar: (1) the longest half-life of any QSC Peptides injectable (~14 days via undecylenate ester), enabling extremely stable blood levels; (2) documented EPO stimulation and erythrocytosis at an intensity greater than testosterone at equivalent doses — potentially through direct renal mechanisms.
With testosterone and EQ both aromatizing to varying degrees, Anavar (non-aromatizing, renal excretion) provides the isolated AR-only anabolic contribution in this protocol — making it possible to study the E2-dependent vs E2-independent contributions to the combined anabolic signal by comparing Anavar's effects to the aromatizing compounds.